A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers.
about
Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics.Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic
P2860
A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@en
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@nl
type
label
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@en
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@nl
prefLabel
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@en
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@nl
P2093
P2860
P356
P1476
A phase I dose-ranging study o ...... r, in healthy male volunteers.
@en
P2093
David K Bol
J Michael Hamilton
Matthew W Harding
Thomas Genna
P2860
P356
10.1177/0091270008325149
P577
2008-10-29T00:00:00Z